Updates to the NCCN Clinical Practice Guidelines in Oncology� for Chronic Myelogenous Leukemia include the addition of PEG-interferon (PEG-IFN) as an alternative to IFN in specified circumstances. Also, for patients not responding to treatment with imatinib, an evaluation of drug-drug interactions was added to the assessment for patient compliance.

The FDA black box warning for nilotinib was added as an attachment to alert clinicians of important considerations with the use of nilotinib. In addition, some of the response categories were reclassified based upon treatment recommendations.

For the complete updated version of the NCCN Clinical Practice Guidelines in Oncology�, please visit NCCN.org.

NCCN Chemotherapy Order Templates� for Anal Carcinoma Added to NCCN.org

Chemotherapy order templates for the treatment of Anal Carcinoma have been added to the library of NCCN Chemotherapy Order Templates� on NCCN.org. The templates include regimens for localized and metastatic disease. Visit the NCCN Chemotherapy Order Templates (subscription required).

E-mail

Mark A A Size

	Quick Links
Clinical Practice Guidelines Drugs & Biologics Compendium Chemotherapy Order Templates Educational Events CME/CE Programs For Patients: NCCN.com Find an NCCN Member Institution Clinical Practice Guidelines Find Clinical Trials Permissions Requests Case Manager Training Member Institution Profiles Clinical Practice Guidelines Drugs & Biologics Compendium Permissions Requests Supporters and Exhibitors Oncology Research Program Corporate Council Permissions Requests NCCN Academy NCCN Business Insights, Research & Analytics NCCN Flash Updates NCCN Trends Surveys Permissions Requests

NCCN Website Supporters